Butorphanol
- Generic Name
- Butorphanol
- Brand Names
- Stadol
- Drug Type
- Small Molecule
- Chemical Formula
- C21H29NO2
- CAS Number
- 42408-82-2
- Unique Ingredient Identifier
- QV897JC36D
- Background
A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain.
- Indication
For the relief of moderate to severe pain.
- Associated Conditions
- Pain, Perioperative Pain, Severe Pain
Study on Gynecological Laparoscopy Under Total Intravenous Anesthesia
Not Applicable
Completed
- Conditions
- Butorphanol
- Interventions
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Wuhan Children's Hospital
- Target Recruit Count
- 59
- Registration Number
- NCT06524596
- Locations
- 🇨🇳
Wuhan Children's hospital, Wuhan, China
Esketamine and Butorphanol for Post-Lobectomy Pain
Phase 4
Completed
- Conditions
- EsketaminePost-thoracotomy Pain SyndromePainThoracic Diseases
- Interventions
- First Posted Date
- 2024-05-03
- Last Posted Date
- 2024-05-06
- Lead Sponsor
- Second People's Hospital of Hefei City
- Target Recruit Count
- 223
- Registration Number
- NCT06398834
- Locations
- 🇨🇳
The Second People's Hospital of Hefei, Hefei, Anhui, China
Butorphanol in Pain Following Ablation for Hepatic Tumor
Not Applicable
Completed
- Conditions
- Visceral PainMicrowave AblationHepatic Tumor
- Interventions
- Drug: normal saline
- First Posted Date
- 2023-09-11
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Bibo Wang
- Target Recruit Count
- 300
- Registration Number
- NCT06031129
- Locations
- 🇨🇳
Jinling Hosipiatl, Nanjing, Jiangsu, China
Efficacy and Safety of Butorphanol Tartrate Injection for the Patients With Mechanical Ventilation
Not Applicable
- Conditions
- Hospital-acquired InfectionsAnalgesia
- Interventions
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05201560
Effect of Different Sedation and Analgesia Strategies on Patients With Mechanical Ventilation
Phase 4
Not yet recruiting
- Conditions
- Respiratory Insufficiency
- Interventions
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2021-08-27
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 300
- Registration Number
- NCT05024799
The Analgesic Effect of Butorphanol After Cesarean Section
- First Posted Date
- 2020-07-29
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04490980
Effect of Butorphanol on Colonoscopy for Patients With Postoperative Visceral Pain
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- Beijing Tiantan Hospital
- Target Recruit Count
- 203
- Registration Number
- NCT04477733
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, China
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
Phase 4
- Conditions
- HydromorphoneAnalgesiaICU
- Interventions
- First Posted Date
- 2020-06-17
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 530
- Registration Number
- NCT04436224
- Locations
- 🇨🇳
Southern medical university Nanfang hospital, Guangzhou, China
Comparison of Analgesic Effect and Prognosis of Butorphanol and Fentanyl in Patients With Mechanical Ventilation
- First Posted Date
- 2020-03-20
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- Jiangsu Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 355
- Registration Number
- NCT04315935
- Locations
- 🇨🇳
Hebei People's Hospital, Hebei, Hebei, China
Using Preoperative Anxiety Score to Determine the Total Dose of Butorphanol for Sedation
Phase 2
Completed
- Conditions
- Total Dose of ButorphanolPreoperative Anxiety Score
- Interventions
- Other: physiological saline
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2019-01-18
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT03810391
- Locations
- 🇨🇳
shengjing hospital of China medical university, Shenyang, Liao Ning, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath